The economic burden of breast cancer for women under 50 in the United States remains largely unexplored, in part because young women make up a small proportion of breast cancer cases overall. To address this knowledge gap, we conducted a web-based survey to compare data from breast cancer survivors 18–39 years of age at first diagnosis and 40–49 years of age at first diagnosis.We administered a survey to a national convenience sample of 416 women who were 18–49 years of age at the time of their breast cancer diagnosis. We analyzed factors associated with financial decline using multivariate regression.Survivors 18–39 years of age at first diagnosis were more likely to report Stage II–IV breast cancer (P < 0.01). They also quit their jobs more often (14.6%) than older survivors (4.4%; P < 0.01) and faced more job performance issues (55.7% and 42.8%, respectively; P = 0.02). For respondents in both groups, financial decline was more likely if the survivor had at least one comorbid condition (odds ratios: 2.36–3.21) or was diagnosed at Stage II–IV breast cancer (odds ratios: 2.04–3.51).

This contributed book covers all aspects concerning the clinical scenario of breast cancer in young women, providing physicians with the latest information on the topic. Young women are a special subset of patients whose care requires dedicated expertise. The book, written and edited by internationally recognized experts who have been directly involved in the international consensus guidelines for breast cancer in young women, pays particular attention to how the disease and its planned treatment can be effectively communicated to young patients. Highly informative and carefully structured, it provides both theoretical and practice-oriented insight for practitioners and professionals involved in the different phases of treatment, from diagnosis to intervention, to follow-up – without neglecting the important role played by prevention.

Current Topics in Breast Cancer Survivorship is an important collection of essays about the health and wellbeing of breast cancer survivors. The audience for the book includes graduate students, health professionals and researchers from many different disciplines, including epidemiology, behavioral science, medicine, oncology, nursing, and health disparities. This book will likely be of interest to health professionals and researchers from various disciplines and members of non-profit organizations, government agencies, and health advocacy organizations. The book is organized into six key sections. The first section provides information about comorbid conditions such as cardiovascular disease, diabetes, and obesity. The second section provides information about lifestyle factors such as physical activity, diet, nutrition, and social determinants of health. The third section provides information about health disparities by age and race/ethnicity. The fourth section provides information about symptoms, including fatigue, sleep disturbance, pain, depression, anxiety, and cognitive impairment. The fifth section provides information about key health services topics, including survivorship care plans and financial hardship. Finally, the sixth section provides a summary and conclusions.

In collaboration with the Breast Cancer Research Foundation (BCRF), this timely volume provides a comprehensive review on all areas of breast cancer survivorship research, highlighting research that is underway or in development. The range of topics covered include the biology and management of fatigue and cognitive dysfunction on breast cancer survivorship, the biology and management of Neuropathy and Arthralgias, the ongoing research on the biology of diet and lifestyle interventions in survivors, and more. With the tremendous growth in the number of breast cancer survivors, researchers have moved beyond describing the outcomes of breast cancer treatments and are focusing their research on understanding the mechanisms underlying the development of the late effects of breast cancer treatment, as well as the development and evaluation of interventions to mitigate some of the persistent symptoms—topics which are also explored in this volume. In addition, current research on how to improve survivorship and reduce recurrence of breast cancer through behavioral and lifestyle modifications is also discussed.

Radiation therapy is a major tool in the management of this family of cancers. This issue of "Radiation Medicine Rounds" includes reviews of all major recent advances in treatment of breast cancer.

This publication gives a comprehensive overview of breast cancer in young women for all members of the healthcare team who treat women with breast cancer. Breast cancer requires multidisciplinary management, and as such this book provides input from epidemiology, basic science, surgical oncology, radiation oncology, medical oncology, plastic and reconstructive surgery, genetics, reproductive endocrinology, psychology and nursing. Because breast cancer in young women occurs during the reproductive years, additional emphasis is placed on managing breast cancer in pregnant patients, as well as reproductive options for breast cancer survivors. The contributors to this volume comprise 30 experts from 6 academic institutions across 10 disciplines. By presenting a clear and comprehensive review of all aspects of breast cancer treatment in young women, the contributors hope to have provided a valuable resource to assist with patient care for all members of the multidisciplinary breast cancer team.

Issues in Cancer Treatment / 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Gene Therapy. The editors have built Issues in Cancer Treatment: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Gene Therapy in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Cancer Treatment / 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Reproductive medicine is a growing field with new technology emerging faster than we can assess consumer’s perceptions of –the number of cancer survivors are growing and there is a great need to attend to their quality of life-this book addresses the needs of males and females, identifies effective communication strategies and proactive measures for health care professionals and researchers to use as well as identifying gaps in the literature where more research is needed.